Form 4: Cibus Inc. Director Gerhard Prante Sells Shares Under 10b5-1 Plan

Director Gerhard Prante of Cibus Inc. sold 2,300 shares of Class A Common Stock in two transactions on January 15th and 16th, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Gerhard Prante, a director at Cibus Inc., sold a total of 2,300 shares of Class A Common Stock.
• The sales occurred in two separate transactions on January 15, 2025, and January 16, 2025.
• On January 15, 2025, 1,150 shares were sold at a price of $2.56 per share.
• On January 16, 2025, another 1,150 shares were sold at a price of $2.75 per share.
• These transactions were executed automatically under a Rule 10b5-1 trading plan adopted on August 16, 2024.
• Following these sales, Mr. Prante's direct holdings decreased to 39,907 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales by a director under a pre-arranged plan. It doesn't indicate any significant positive or negative sentiment.

Risks

• The sale of shares by a director could be perceived negatively by the market, potentially impacting the stock price.
• The use of a 10b5-1 plan indicates a pre-determined selling strategy, which may not reflect the director's current outlook on the company's future.

Industry Context

This is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among corporate insiders to manage their stock sales and avoid potential insider trading accusations, similar to practices seen at companies like Monsanto (now Bayer) and Corteva.
• The volume of shares sold is relatively small compared to the total outstanding shares of Cibus Inc., which is typical for routine insider sales.
• The price range of $2.56 to $2.75 per share is within the normal fluctuations of a publicly traded stock, and similar price movements can be observed in other agricultural biotech companies.

Stakeholder Impact

• The sale of shares by a director may cause a slight negative reaction from shareholders, but the impact is likely to be minimal due to the small volume of shares sold and the pre-arranged nature of the transactions.

Key Dates

Keywords

Cibus Inc., Gerhard Prante, insider trading, Form 4, 10b5-1 plan, stock sale, director, Class A Common Stock